Brandenburg Kapital - News about Emperra GmbH E-Health Technologies
EMPERRA shows convincing efficacy data for digital diabetes management platform ESYSTA
Potsdam - august 2024 - EMPERRA E-Health Technologies has demonstrated the effectiveness of its digital diabetes management platform ESYSTA in scientific studies with over 1,200 participants. The studies show a significant improvement in therapy for insulin-treated diabetes patients. The company is now seeking reimbursement for ESYSTA as a standard service via digital health applications (DiGA) and through contracts with health insurance companies.
EMPERRA E-Health Technologies is a portfolio company of Brandenburg Kapital GmbH, which supported the product development early on.
Read the complete presse release in the download area.
Further information can be found at: www.brandenburg-kapital.de, www.emperra.com